| Bioactivity | Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive disorders[1][3]. |
| Target | Dopamine receptor |
| In Vivo | Alizapride (2.5, 5, 10, 25 μg/kg; SC; 7 consecutive days) significantly reduces the bound IgG-sensitized erythrocytes with Splenic macrophages isolated from animals[2]. Animal Model: |
| Name | Alizapride hydrochloride |
| CAS | 59338-87-3 |
| Formula | C16H22ClN5O2 |
| Molar Mass | 351.83 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Bleiberg H, et al. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. |
Alizapride hydrochloride
CAS: 59338-87-3 F: C16H22ClN5O2 W: 351.83
Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive dis
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.